Evidence for endocytosis-dependent proteolysis in the generation of soluble truncated nerve growth factor receptors by A875 human melanoma cells.
We have identified nerve growth factor receptor (NGFR) on the cell surface and a truncated nerve growth factor receptor (NGFRt) in the conditioned medium of NGFR-negative cells that have been transfected with either the gene or the cDNA for the full-length receptor. By using cell surface iodination or metabolic labeling of A875 human melanoma cells, coupled with immunoprecipitation, we have determined the half-life of the cell-associated receptor to be approximately 7 h. Concomitant with receptor degradation is the accumulation of NGFRt in the extracellular medium. Approximately one-fifth of the labeled receptor can be recovered as the truncated species. These data support the hypothesis that NGFRt is generated by proteolysis of previously intact receptor. Furthermore, although no specific protease inhibitor assayed could affect this processing, NGFR degradation and truncation were retarded by treatment with: 1) the weak base amines, ammonium chloride or methylamine; 2) the carboxylic ionophore, monensin; or 3) the vacuolar ATPase inhibitor, bafilomycin A1, all agents that dissipate endosomal/lysosomal proton gradients via alternate mechanisms. Incubation of cells at 4 degrees C precluded NGFR degradation and truncation. The presence of ligand did not alter the time course of receptor truncation.
Zupan
A A
AA
Department of Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110.
Johnson
E M
EM
D000643:Ammonium Chloride / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015153:Blotting, Western; D004247:DNA / Q000235:genetics; D004591:Electrophoresis, Polyacrylamide Gel; D004705:Endocytosis; D010450:Endopeptidases / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D018942:Macrolides; D008545:Melanoma; D008744:Methylamines / Q000494:pharmacology; D008985:Monensin / Q000494:pharmacology; D011233:Precipitin Tests; D011480:Protease Inhibitors / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D017475:Receptors, Nerve Growth Factor; D014162:Transfection; D014407:Tumor Cells, Cultured
D000900:Anti-Bacterial Agents; D018942:Macrolides; D008744:Methylamines; D011480:Protease Inhibitors; D011956:Receptors, Cell Surface; D017475:Receptors, Nerve Growth Factor; D000643:Ammonium Chloride; C057620:bafilomycin A; D004247:DNA; D008985:Monensin; C027451:methylamine; D010450:Endopeptidases